Y－氨基丁酸的作用

1、镇静神经、抗焦虑。医学家已经证明GABA是中枢神经系统的抑制性传递物质，是脑组织中最重要的神经递质之一。其作用是降低神经元活性，防止神经细胞过热。

2、降低血压。GABA能作用于脊髓的血管运动中枢，有效促进血管扩张，达到降低血压的目的。

3、治疗疾病。

4、降低血氨。摄入GABA可以提高葡萄糖磷酸酯酶的活性，使脑细胞活动旺盛，可促进脑组织的新陈代谢和恢复脑细胞功能，改善神经机能。

5、提高脑活力。

GABA能进入脑内三羧酸循环，促进脑细胞代谢，同时还能提高葡萄糖代谢时葡萄糖磷酸酯酶的活性，增加乙酰胆碱的生成，扩张血管增加血流量，并降低血氨，促进大脑的新陈代谢，恢复脑细胞功能。

6、促进乙醇代谢。以嗜酒者为对象，服用GABA再饮用60ml威士忌后采血测定血中乙醇及 浓度，发现后者浓度明显比对照组低。

7、GABA还具有防止皮肤老化、消除体臭、改善脂质代谢，防止动脉硬化高效减肥等功能。

产品详询：13657416805

1. References:
2. 1. 

   É. A. Bendikov and V. G. Butuzov, in: The Pharmacology of Monoaminergic Processes [in Russian], Moscow (1971), p. 24.

3. 2. 

   É. A. Bendikov and V. G. Butuzov, in: The Pharmacology of Monoaminergic Processes [in Russian], Moscow (1971), p. 42.

4. 3. 

   É. A. Bendikov and V. G. Butuzov, in: The Pharmacology of Monoaminergic Processes [in Russian], Moscow (1971), p. 53.

5. 4. 

   V. G. Butuzov and É. A. Bendikov, Farmakol. i Toksikol., No. 5, 535 (1969). 

6. 5. 

   N. A. Esayan, A. R. Armenyan, and L. N. Arakelyan, in: Problems in Biochemistry of the Brain [in Russian], part 3, Erevan (1967), p. 313.

7. 6. 

   V. V. Zakusov, Vestn. Akad. Med. Nauk SSSR, No. 4, 43 (1964).

8. 7. 

   V. V. Zakusov (editor), Sodium Hydroxybutyrate [in Russian], Moscow (1968).

9. 8. 

   N. V. Kaverina and Yu. B. Rozonov, Byull. Éksperim. Biol. i Med., No. 2, 60 (1966).

10. 9. 

    N. A. Kruglov and R. I. Kvasnoi, in: Sodium Hydroxybutyrate [in Russian], Moscow (1968), p. 48.

11. 10. 

    S. A. Mirzoyan, B. A. Kazaryan, and V. P. Akopyan, in: Current Problems in Pharmacology [in Russian], Kiev (1971), p. 184.

12. 11. 

    S. A. Mirzoyan and R. G. Boroyan, in: Problems in Biochemistry of the Brain [in Russian], part 3, Erevan (1967), p. 117.

13. 12. 

    R. U. Ostrovskaya, N. M. Tsybina, T. V. Protopopova, et al., Khim.-Farmets. Zh., No. 12, 21 (1969).

14. 13. 

    R. A. Khaunina and M. N. Maslova, in: Problems in Psychiatry and Neuropathology [in Russian], No. 13, Leningrad (1968), p. 583.

15. 14. 

    J. C. Eccles, The Physiology of Synapses, Springer, Berlin (1964).

16. 15. 

    D. P. Becker, H. F. Young, F. E. Nielsen, et al., Exp. Neurol.,24, 272 (1969).

17. 16. 

    D. R. Curtis, A. W. Duggon, and D. Felix, Brain Res.,23, 117 (1970). 

18. 17. 

    D. R. Curtis, D. Felix and H. McLenna, Brit. J. Pharmacol.,40, 881 (1970).

19. 18. 

    A. Halpern and G. Neck, United States Patent No. 3172, 8.12 (1965).

20. 19. 

    T. Hayashi, Hospital (Rio),75, 109 (1969).

21. 20. 

    H. Laborit, Internat. J. Neuropharmacol.,3, 433 (1964).